skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

0004 Salidroside Ameliorates Chronic Intermittent Hypoxia-induced Endothelial Insulin Resistance via Suppression of ERK1/2 Activation

Sleep (New York, N.Y.), 2018-04, Vol.41 (suppl_1), p.A1-A2 [Peer Reviewed Journal]

Sleep Research Society 2018. Published by Oxford University Press [on behalf of the Sleep Research Society]. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;Copyright © 2018 Sleep Research Society ;ISSN: 0161-8105 ;EISSN: 1550-9109 ;DOI: 10.1093/sleep/zsy061.003

Full text available

Citations Cited by
  • Title:
    0004 Salidroside Ameliorates Chronic Intermittent Hypoxia-induced Endothelial Insulin Resistance via Suppression of ERK1/2 Activation
  • Author: Li, L ; Yang, Y ; Ma, X ; Wei, Y ; Qin, Y
  • Subjects: Hypoxia ; Insulin resistance ; Kinases ; Phosphorylation
  • Is Part Of: Sleep (New York, N.Y.), 2018-04, Vol.41 (suppl_1), p.A1-A2
  • Description: Abstract Introduction Obstructive sleep apnea (OSA), a condition leading to chronic intermittent hypoxia (CIH), is an independent risk factor for cardiovascular disease and type 2 diabetes and is correlated with insulin resistance. Insulin stimulates production of nitric oxide (NO) in vascular endothelial cells through the IRS-1/PI3K/Akt/eNOS pathway (IRS-1, insulin receptor substrate 1; PI3K, phosphatidylinositol 3-kinase; eNOS, endothelial NO synthase). We wondered if CIH that mimic OSA affects insulin signalling/action both in the aortas of C57BL/6J mice and in the human umbilical vein endothelial cells (HUVECs), and whether salidroside (Sali), a major active constituent of Rhodiola sachalinensis, could reverse this inhibitory effect. Methods Forty male C57BL/6J mice were randomly divided into four groups (n=10/group): (1) control (intermittent air), (2) CIH (21%-5%, 90 s/cycle, 10 h/day), (3) CIH+50 mg/kg Sali, (4) CIH+100 mg/kg Sali, 7 weeks intervention. HUVECs were treated with 10 uM or 100 uM of Sali and exposed to CIH (21%-5%, 1 h/cycle) for 24 h or 48 h with or without insulin. Blood pressure, endothelium-dependent relaxation (EDR) and insulin-stimulated activation of signal molecules were assessed. Results We observed that CIH increased systolic blood pressure and impaired EDR of aortas in C57BL/6J mice. CIH increased IRS-1 phosphorylation at Ser307 and Ser612, impaired insulin-stimulated phosphorylation of IRS-1 at Tyr896 and Akt/eNOS pathway in aortas. In addition, CIH increased extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation. Treatment of C57BL/6J mice with Sali dose-dependently ameliorated theses deleterious effects of CIH. In vitro, CIH impaired IRS-1/PI3K/Akt/eNOS pathway that resulted in reduced insulin-stimulated NO production in HUVECs. These events were accompanied by elevated ERK1/2 phosphorylation and were reversed by ERK1/2 inhibition. Sali improved endothelial insulin resistance by inhibition of ERK1/2 activation, leading to positive regulation of serine/tyrosine phosphorylation of IRS-1 and restoration of downstream Akt/eNOS activation and insulin-mediated NO production. Conclusion Our data suggest that CIH may cause endothelial insulin resistance by dysregulation of IRS-1 serine/tyrosine phosphorylation via ERK1/2. Salidroside is effective in ameliorating CIH-induced insulin resistant endothelial dysfunction by inhibition ERK1/2 activation and beneficial regulation of IRS-1 function. Support (If Any) N/A.
  • Publisher: US: Oxford University Press
  • Language: English
  • Identifier: ISSN: 0161-8105
    EISSN: 1550-9109
    DOI: 10.1093/sleep/zsy061.003
  • Source: ProQuest One Psychology
    Alma/SFX Local Collection
    ProQuest Central

Searching Remote Databases, Please Wait